Navidea Biopharmaceuticals Receives Complete Response Letter from FDA for Lymphoseek® NDA Due to Manufacturing Deficiencies Sep 10, 2012
Navidea Biopharmaceuticals Names Pharma Industry Veteran Cornelia Reininger, M.D., Ph.D., as Chief Medical Officer Sep 5, 2012
Navidea Biopharmaceuticals Second Quarter 2012 Earnings and Business Update Conference Call Invitation Jul 30, 2012
Navidea Biopharmaceuticals Announces $50 Million Credit Facility with Platinum-Montaur Life Sciences Jul 26, 2012
Lymphoseek® Data Presented by Independent Investigators at 8th International Conference on Head and Neck Cancer Jul 26, 2012
Head-to-Head Study Comparing Navidea’s AZD4694 to the Gold Standard for Imaging Beta Amyloid Protein Deposits Presented at Alzheimer's Association International Conference Jul 23, 2012
